I don’t doubt the “heart and mind in the right place”. This job though is about a lot more than that. It is not OJT (as they are doing). I am glad to have a choice at the next meeting and if nothing else it puts current management on watch to get competent resources in place to design and complete trials properly - starting with the CEO. He is grossly incompetent.
No disrespect to the posters who support NP/SK. We all have our positions and opinions. We can agree to disagree and we all want the same - Leronlimab to be approved ASAP.
News 
Market Data 
Discover 
